Spectrum Pharmaceuticals Inc Premium Company Profile Introduction
Spectrum Pharmaceuticals (Spectrum) is a biopharmaceutical company with a diversified portfolio of generic products and a pipeline of proprietary and collaborative products. Its therapeutic focus is on various cancer indications,... |
Stakeholder Insight: Major Depressive Disorder Gaining traction among physicians is crucial in an SSRI-dominated market Prescribing trends reveal that the MDD market is receptive to alternative modes of actions at later lines of therapy, while traditional classes dominate earlier lines. Favorable physician perception is crucial... |
Pediatric Health Care Products and Services Study Goal and Objectives
The aim of this study is to provide an in-depth analysis and forecast of the pediatric healthcare market. The focus is on scope of the market, including... |
Attention-Deficit Hyperactivity Disorder Market Forecast Introduction
Driven primarily by continued uptake of Shire's market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408)... |
Attention-Deficit Hyperactivity Disorder (ADHD) Competitor Analysis Product description
The present Competitive Intelligence Report about Attention-Deficit Hyperactivity Disoder (ADHD) provides a competitor evaluation in the field of approved and investigational drugs for treatment of ADHD as of March... |
Pediatric Drugs: the Worldwide Market 3rd Edition Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the... |
Emotional and Behavioral Disorders in Children and Adolescents The emotional and behavioral disorder drug market is changing as a result of the heightened awareness of these diseases in young children and adolescents and the use of drugs dedicated... |
CNS Therapeutics A World Market Review While the available CNS therapies can slow down deteriorating condition of patient, the clinical pipeline boasts of new drug classes with potential to stop or reverse the disease's progression. Continuing... |
Neurological Disorders - Physician Perspective 2008 U.S. Drug Delivery This research service encompasses feedback on aspects of drug delivery and drug treatment provided by physicians in the U.S. who treat neurological disorders in order to enable interested stakeholders to... |
Therapeutic Drugs for Central Nervous System (CNS) Disorders Technologies and Global Markets This Report Contains
Discussion of such disease areas as psychotherapeutics, seizure, ADHD, insomnia, migraines, and Parkinson's
Analysis of global market trends, with data for 2009, estimates for 2010, and projections of compound... |
R&D Trends: Attention-Deficit Hyperactivity Disorder Growing pipeline indicates a trend towards adjunctive and adult therapy Introduction
Two drugs have progressed through the pipeline representing the first two products to receive US FDA approval for use as adjunctive therapies to stimulants: Intuniv (extended release guanfacine; Shire) and... |
Nanotechnology in Healthcare Market Outlook for Applications, Tools and Materials, and 40 Company Profiles The CNS disorders market may be segmented into numerous subcategories, including major depressive disorder (MDD), epilepsy, schizophrenia, Alzheimer's disease (AD), Parkinson's disease (PD), migraine, insomnia, attention-deficit hyperactivity disorder (ADHD), bipolar... |
Attention Deficit Disorder with Hyperactivity Therapy Area Pipeline Report Life Science Analytics', Attention Deficit Disorder with Hyperactivity Therapy Area Pipeline Report contains detailed information on the attention deficit disorder with hyperactivity drug pipeline. This report provides insight into the... |
CNS Therapeutics This report analyzes the worldwide markets for CNS Therapeutics in Millions of US$. The specific product Groups analyzed are Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management (includes Migraine, Nociceptive and neuropathic pain),... |
ADHD Therapeutics This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US and Rest of World. Annual estimates and forecasts... |
Attention Deficit Disorder Global Clinical Trials Review Q1, 2011 Attention Deficit Disorder Global Clinical Trials Review, Q1, 2011
Summary
GlobalData's clinical trial report, "Attention Deficit Disorder Global Clinical Trials Review, Q1, 2011" provides data on the Attention Deficit Disorder ... |
Stakeholder Opinions: Female Sexual Dysfunction Results from Datamonitor's 2005 physician survey Introduction
Patients in a clinical population receive drug and non-drug therapy for female sexual dysfunction, yet a third remain refractory to treatment, highlighting a need for a formally approved product for... |
Pediatric Drugs and Vaccines This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Product Segments: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS... |
Gastrointestinal Disorder Therapeutics to 2016 High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets GBI Research's report, "Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets", provides in-depth analysis of the unmet needs,... |
The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis GBI Research, the leading business intelligence provider, has released its latest research "The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and... |
NeuroDerm Ltd. - Product Pipeline Review Q4 2010 NeuroDerm Ltd. - Product Pipeline Review - Q4 2010
Summary
Global Market Directs pharmaceuticals report, "NeuroDerm Ltd. - Product Pipeline Review - Q4 2010" provides data on the companys research and development... |